Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Isabel Legaz, M. D. Pérez-Cárceles, Irene de la Calle, Fuensanta Arjona, Miriam Roca, Pablo Cejudo, Aurelio Luna & Eduardo Osuna. (2021) Genetic susceptibility to nicotine and/or alcohol addiction: a systematic review. Toxin Reviews 40:4, pages 371-382.
Read now
Read now
Nikki Bozinoff & Bernard Le Foll. (2018) Understanding the implications of the biobehavioral basis of nicotine addiction and its impact on the efficacy of treatment. Expert Review of Respiratory Medicine 12:9, pages 793-804.
Read now
Read now
Articles from other publishers (40)
Lulu Guo, Jian Mao, Qidong Zhang, Wu Fan, Dingzhong Wang, Zhonghao Li, Jiaqiang Huang & Jianping Xie. (2023) Pharmacokinetic and pharmacodynamic studies of nicotine in rat brain: a simultaneous investigation of nicotine metabolites and the release of neurotransmitters in vivo. Frontiers in Chemistry 11.
Crossref
Crossref
Yadira X. Perez-Paramo, Christy J.W. Watson, Gang Chen & Philip Lazarus. (2023)
CYP2C19 Plays a Major Role in the Hepatic
N
-Oxidation of Cotinine
. Drug Metabolism and Disposition 51:1, pages 29-37.
Crossref
Crossref
Hongliang Liu, Guojun Li, Erich M. Sturgis, Sanjay Shete, Kristina R. Dahlstrom, Mulong Du, Christopher I. Amos, David C. Christiani, Philip Lazarus & Qingyi Wei. (2022)
Genetic variants in
CYP2B6
and
HSD17B12
associated with risk of squamous cell carcinoma of the head and neck
. International Journal of Cancer 151:4, pages 553-564.
Crossref
Crossref
Meghan J. Chenoweth, Annie R. Peng, Andy Z. X. Zhu, Lisa Sanderson Cox, Nikki L. Nollen, Jasjit S. Ahluwalia, Neal L. Benowitz, Jo Knight, Walter Swardfager & Rachel F. Tyndale. (2021)
Does sex alter the relationship between
CYP2B6
variation, hydroxybupropion concentration and bupropion‐aided smoking cessation in African Americans? A moderated mediation analysis
. Addiction 117:6, pages 1715-1724.
Crossref
Crossref
Katalin Mangó, Ádám Ferenc Kiss, Ferenc Fekete, Réka Erdős & Katalin Monostory. (2022) CYP2B6 allelic variants and non-genetic factors influence CYP2B6 enzyme function. Scientific Reports 12:1.
Crossref
Crossref
Karen D. Vo & Mary F. Paine. 2022. Atkinson's Principles of Clinical Pharmacology. Atkinson's Principles of Clinical Pharmacology
405
424
.
Seenae Eum, Franklin Sayre, Adam M. Lee, Julia C. Stingl & Jeffrey R. Bishop. (2021)
Association of
CYP2B6
genetic polymorphisms with bupropion and hydroxybupropion exposure: A systematic review and meta‐analysis
. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 42:1, pages 34-44.
Crossref
Crossref
Ahmed El‐Boraie & Rachel F. Tyndale. (2021) The Role of Pharmacogenetics in Smoking. Clinical Pharmacology & Therapeutics 110:3, pages 599-606.
Crossref
Crossref
Zeruesenay Desta, Ahmed El‐Boraie, Li Gong, Andrew A Somogyi, Volker M. Lauschke, Collet Dandara, Kathrin Klein, Neil A. Miller, Teri E. Klein, Rachel F. Tyndale, Michelle Whirl‐Carrillo & Andrea Gaedigk. (2021)
PharmVar GeneFocus:
CYP2B6
. Clinical Pharmacology & Therapeutics 110:1, pages 82-97.
Crossref
Crossref
Ahmet Muderrisoglu, Elif Babaoglu, Elif Tugce Korkmaz, Mert C. Ongun, Erdem Karabulut, Alper B. Iskit, Salih Emri & Melih O. Babaoglu. (2020) Effects of Genetic Polymorphisms of Drug Transporter ABCB1 (MDR1) and Cytochrome P450 Enzymes CYP2A6, CYP2B6 on Nicotine Addiction and Smoking Cessation. Frontiers in Genetics 11.
Crossref
Crossref
Gissela Borrego-Soto, Yadira X. Perez-Paramo, Gang Chen, Sandra K. Santuario-Facio, Jesus Santos-Guzman, Rodolfo Posadas-Valay, Fatima M. Alvarado-Monroy, Isaias Balderas-Renteria, Ramses Medina-Gonzalez, Rocio Ortiz-Lopez, Philip Lazarus & Augusto Rojas-Martinez. (2020) Genetic variants in CYP2A6 and UGT1A9 genes associated with urinary nicotine metabolites in young Mexican smokers. The Pharmacogenomics Journal 20:4, pages 586-594.
Crossref
Crossref
Irvin R. Schultz, Li-Jung Kuo, Valerie Cullinan & Sara Cade. (2020) Occupational and dietary differences in hydroxylated and methoxylated PBDEs and metals in plasma from Puget Sound, Washington, USA region volunteers. Science of The Total Environment 714, pages 136566.
Crossref
Crossref
Edward D Levin, Corinne Wells, Susan Slade, Michelle Lee, Anthony A McKinney, Jed E Rose & Amir H Rezvani. (2020) Prolonging the Reduction of Nicotine Self-Administration in Rats by Coadministering Chronic Nicotine With Amitifadine, a Triple Monoamine Reuptake Inhibitor With CYP2B6 Inhibitory Actions. Nicotine & Tobacco Research 22:2, pages 232-237.
Crossref
Crossref
Adam Joseph Bloom, Pan‐Fen Wang & Evan D. Kharasch. (2019)
Nicotine oxidation by genetic variants of
CYP
2B6 and in human brain microsomes
. Pharmacology Research & Perspectives 7:2, pages e00468.
Crossref
Crossref
Taraneh Taghavi & Rachel F. Tyndale. 2019. Neuroscience of Nicotine. Neuroscience of Nicotine
499
507
.
Taraneh Taghavi, Christopher A. Arger, Sarah H. Heil, Stephen T. Higgins & Rachel F. Tyndale. (2018) Longitudinal Influence of Pregnancy on Nicotine Metabolic Pathways. Journal of Pharmacology and Experimental Therapeutics 364:2, pages 238-245.
Crossref
Crossref
Lei Li, Qing-Yu Zhang & Xinxin Ding. (2018) A CYP2B6-humanized mouse model and its potential applications. Drug Metabolism and Pharmacokinetics 33:1, pages 2-8.
Crossref
Crossref
Aleksi Tornio & Janne T. Backman. 2018. Pharmacogenetics. Pharmacogenetics
3
32
.
Julie-Anne Tanner & Rachel Tyndale. (2017) Variation in CYP2A6 Activity and Personalized Medicine. Journal of Personalized Medicine 7:4, pages 18.
Crossref
Crossref
Nora A. Gutierrez Najera, Osbaldo Resendis-Antonio & Humberto Nicolini. (2017) “Gestaltomics”: Systems Biology Schemes for the Study of Neuropsychiatric Diseases. Frontiers in Physiology 8.
Crossref
Crossref
Yasuhiro Uno, Ryo Takata, Go Kito, Hiroshi Yamazaki, Kazuko Nakagawa, Yusuke Nakamura, Tetsuya Kamataki & Toyomasa Katagiri. (2017) Sex- and age-dependent gene expression in human liver: An implication for drug-metabolizing enzymes. Drug Metabolism and Pharmacokinetics 32:1, pages 100-107.
Crossref
Crossref
Meghan J. Chenoweth & Rachel F. Tyndale. (2017) Pharmacogenetic Optimization of Smoking Cessation Treatment. Trends in Pharmacological Sciences 38:1, pages 55-66.
Crossref
Crossref
R. E. Pearce, R. Gaedigk, G. P. Twist, H. Dai, A. K. Riffel, J. S. Leeder & A. Gaedigk. (2015) Developmental Expression of CYP2B6: A Comprehensive Analysis of mRNA Expression, Protein Content and Bupropion Hydroxylase Activity and the Impact of Genetic Variation. Drug Metabolism and Disposition 44:7, pages 948-958.
Crossref
Crossref
Meghan J. Chenoweth, Marie-Pierre Sylvestre, Gisele Contreras, Maria Novalen, Jennifer O’Loughlin & Rachel F. Tyndale. (2016) Variation in CYP2A6 and tobacco dependence throughout adolescence and in young adult smokers. Drug and Alcohol Dependence 158, pages 139-146.
Crossref
Crossref
Bernard Le Foll. 2016. Neuroscience for Addiction Medicine: From Prevention to Rehabilitation - Methods and Interventions. Neuroscience for Addiction Medicine: From Prevention to Rehabilitation - Methods and Interventions
419
447
.
Henk van den Berg, Michael Paulussen, Gwénaël Le Teuff, Ian Judson, Hans Gelderblom, Uta Dirksen, Bernadette Brennan, Jeremy Whelan, Ruth Lydia Ladenstein, Perrine Marec-Berard, Jarmila Kruseova, Lars Hjorth, Thomas Kühne, Benedicte Brichard, Keith Wheatley, Alan Craft, Heribert Juergens, Nathalie Gaspar & Marie-Cécile Le Deley. (2015) Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: Secondary analysis of the Euro-Ewing99-R1 trial. European Journal of Cancer 51:16, pages 2453-2464.
Crossref
Crossref
Zhihua Liu, Lei Li, Hong Wu, Jing Hu, Jun Ma, Qing-Yu Zhang & Xinxin Ding. (2015) Characterization of CYP2B6 in a CYP2B6-Humanized Mouse Model: Inducibility in the Liver by Phenobarbital and Dexamethasone and Role in Nicotine Metabolism In Vivo. Drug Metabolism and Disposition 43:2, pages 208-216.
Crossref
Crossref
Julie-Anne Tanner, Meghan J. Chenoweth & Rachel F. Tyndale. 2015. The Neurobiology and Genetics of Nicotine and Tobacco. The Neurobiology and Genetics of Nicotine and Tobacco
37
86
.
F. Peter Guengerich. 2015. Cytochrome P450. Cytochrome P450
523
785
.
A. Joseph Bloom, Maribel Martinez, Li-Shiun Chen, Laura J. Bierut, Sharon E. Murphy & Alison Goate. (2013) CYP2B6 Non-Coding Variation Associated with Smoking Cessation Is Also Associated with Differences in Allelic Expression, Splicing, and Nicotine Metabolism Independent of Common Amino-Acid Changes. PLoS ONE 8:11, pages e79700.
Crossref
Crossref
Catherine Wassenaar, Qiong Dong, Christopher Amos, Margaret Spitz & Rachel Tyndale. (2013) Pilot Study of CYP2B6 Genetic Variation to Explore the Contribution of Nitrosamine Activation to Lung Carcinogenesis. International Journal of Molecular Sciences 14:4, pages 8381-8392.
Crossref
Crossref
Andy Z.X. Zhu, Caroline C. Renner, Dorothy K. Hatsukami, Gary E. Swan, Caryn Lerman, Neal L. Benowitz & Rachel F. Tyndale. (2013) The Ability of Plasma Cotinine to Predict Nicotine and Carcinogen Exposure is Altered by Differences in CYP2A6: the Influence of Genetics, Race, and Sex. Cancer Epidemiology, Biomarkers & Prevention 22:4, pages 708-718.
Crossref
Crossref
Neal L. Benowitz, Andy Z. X. Zhu, Rachel F. Tyndale, Delia Dempsey & Peyton Jacob. (2013) Influence of CYP2B6 genetic variants on plasma and urine concentrations of bupropion and metabolites at steady state. Pharmacogenetics and Genomics 23:3, pages 135-141.
Crossref
Crossref
C. S. Ferguson, S. Miksys, R. M. Palmour & R. F. Tyndale. (2012) Differential Effects of Nicotine Treatment and Ethanol Self-Administration on CYP2A6, CYP2B6 and Nicotine Pharmacokinetics in African Green Monkeys. Journal of Pharmacology and Experimental Therapeutics 343:3, pages 628-637.
Crossref
Crossref
A Z X Zhu, L S Cox, N Nollen, B Faseru, K S Okuyemi, J S Ahluwalia, N L Benowitz & R F Tyndale. (2012) CYP2B6 and Bupropion’s Smoking-Cessation Pharmacology: The Role of Hydroxybupropion. Clinical Pharmacology & Therapeutics 92:6, pages 771-777.
Crossref
Crossref
Ellen M. McDonagh, Catherine Wassenaar, Sean P. David, Rachel F. Tyndale, Russ B. Altman, Michelle Whirl-Carrillo & Teri E. Klein. (2012) PharmGKB summary. Pharmacogenetics and Genomics 22:9, pages 695-708.
Crossref
Crossref
Matthew J. Binnington, Andy Z.X. Zhu, Caroline C. Renner, Anne P. Lanier, Dorothy K. Hatsukami, Neal L. Benowitz & Rachel F. Tyndale. (2012) CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people. Pharmacogenetics and Genomics 22:6, pages 429-440.
Crossref
Crossref
Andy Z. X. Zhu & Rachel F. Tyndale. 2012. Metabolism of Drugs and Other Xenobiotics. Metabolism of Drugs and Other Xenobiotics
465
492
.
Irena Loryan, Marja Lindqvist, Inger Johansson, Masahiro Hiratsuka, Ilse van der Heiden, Ron HN van Schaik, Jan Jakobsson & Magnus Ingelman-Sundberg. (2011) Influence of sex on propofol metabolism, a pilot study: implications for propofol anesthesia. European Journal of Clinical Pharmacology 68:4, pages 397-406.
Crossref
Crossref
Alexander V. LyubimovThomas K. H. Chang & David J. Waxman. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
19
.